(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...

AstraZeneca ( ($AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca is ...

Fueled by gains in all of its therapeutic areas, the company had a triumphant third quarter.

The “most favored nation” (MFN) drug pricing deal AstraZeneca recently signed with the Trump administration won’t affect the ...

China's clear message to support the development of innovative drugs has buoyed the spirits of foreign pharmaceutical companies and reinforced their commitments to align their global R&D capabilities ...

The chief scientific officer of AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of company sales in five ...

AstraZeneca Pharmaceuticals was hit with an employment discrimination lawsuit on Oct. 17 in New Mexico District Court for Bernalillo County. The action, brought by Saucedo Harrigan Apodaca Griesmeyer ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare.

UK finance minister Rachel Reeves said the country expects increased investment from pharmaceutical companies if it agrees to raise drug prices as part of ongoing trade talks. U.S. President Donald ...

AstraZeneca said it will invest $445 million to expand a Texas facility that produces Lokelma, its treatment for high potassium levels in adults. The pharmaceutical company said Wednesday it will add ...